Page last updated: 2024-08-16

moxonidine and metformin

moxonidine has been researched along with metformin in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (44.44)	29.6817
2010's	5 (55.56)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Campillo, NE; Guerra, A; Páez, JA	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A	1
Glezer, MG; Ignat'ev, IV; Karpov, IuA; Kobalava, ZhD; Konradi, AO; Kuzin, AI; Tolkacheva, VV; Zheleznykh, EA	1
Almazov, VA; Chazova, I; Shlyakhto, E	1
Balink, H; de Graaf, W; Grond, J; Hemmelder, MH	1

Trials

2 trial(s) available for moxonidine and metformin

Article	Year
[Clinicogenetic aspects of carbohydrate metabolism disorders and efficacy of their correction with moxonidine and metformine in patients with arterial hypertension]. Terapevticheskii arkhiv, 2005, Volume: 77, Issue:1 Topics: Adult; Aged; Alleles; Antihypertensive Agents; Blood Pressure; Carbohydrate Metabolism; DNA; Female; Follow-Up Studies; Genetic Markers; Glucose Metabolism Disorders; Humans; Hypertension; Hypoglycemic Agents; Imidazoles; Insulin; Insulin Receptor Substrate Proteins; Intracellular Signaling Peptides and Proteins; Male; Metformin; Middle Aged; Phosphoproteins; Polymerase Chain Reaction; Polymorphism, Genetic; PPAR alpha; PPAR gamma; Treatment Outcome	2005
Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin. Diabetes, obesity & metabolism, 2006, Volume: 8, Issue:4 Topics: Adult; Aged; Antihypertensive Agents; Blood Glucose; Body Mass Index; Double-Blind Method; Female; Glucose Tolerance Test; Humans; Hypertension; Hypoglycemic Agents; Imidazoles; Insulin; Insulin Resistance; Male; Metabolic Syndrome; Metformin; Middle Aged; Overweight; Prospective Studies; Treatment Outcome	2006

Article

Year

[Clinicogenetic aspects of carbohydrate metabolism disorders and efficacy of their correction with moxonidine and metformine in patients with arterial hypertension].

Terapevticheskii arkhiv, 2005, Volume: 77, Issue:1

Topics: Adult; Aged; Alleles; Antihypertensive Agents; Blood Pressure; Carbohydrate Metabolism; DNA; Female; Follow-Up Studies; Genetic Markers; Glucose Metabolism Disorders; Humans; Hypertension; Hypoglycemic Agents; Imidazoles; Insulin; Insulin Receptor Substrate Proteins; Intracellular Signaling Peptides and Proteins; Male; Metformin; Middle Aged; Phosphoproteins; Polymerase Chain Reaction; Polymorphism, Genetic; PPAR alpha; PPAR gamma; Treatment Outcome

2005

Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin.

Diabetes, obesity & metabolism, 2006, Volume: 8, Issue:4

Topics: Adult; Aged; Antihypertensive Agents; Blood Glucose; Body Mass Index; Double-Blind Method; Female; Glucose Tolerance Test; Humans; Hypertension; Hypoglycemic Agents; Imidazoles; Insulin; Insulin Resistance; Male; Metabolic Syndrome; Metformin; Middle Aged; Overweight; Prospective Studies; Treatment Outcome

2006

Other Studies

7 other study(ies) available for moxonidine and metformin

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Neural computational prediction of oral drug absorption based on CODES 2D descriptors. European journal of medicinal chemistry, 2010, Volume: 45, Issue:3 Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Prediction of drug intestinal absorption by new linear and non-linear QSPR. European journal of medicinal chemistry, 2011, Volume: 46, Issue:1 Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics	2011
Scintigraphic diagnosis of Erdheim-Chester disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Jun-01, Volume: 29, Issue:16 Topics: Aged; Amlodipine; Antihypertensive Agents; Diabetes Mellitus, Type 2; Drug Combinations; Erdheim-Chester Disease; Gated Blood-Pool Imaging; Humans; Hydrochlorothiazide; Hypoglycemic Agents; Hypolipidemic Agents; Imidazoles; Knee Joint; Losartan; Male; Metformin; Positron-Emission Tomography; Prostatic Neoplasms; Simvastatin	2011